<unk> , also known as 5-(3-pyridinylmethyl)benzofurancarboxylic acid, is a chemical compound with thromboxane enzyme inhibiting properties that was originally developed by Pharmacia Corporation as a drug to treat arrhythmias, ischaemic heart disorders, and thrombosis but was discontinued. It is commercially available in the form<unk>  sodium salt.<unk>  is able to bind to the enzyme thromboxane A2 synthase. By binding to thromboxane A2 synthase it negates the effects and prevents it from acting like a vasoconstrictor. Because of this<unk>  is capable of preventing several diseases involving thrombosis, the occurrence of blood clots that block veins or arteries.<unk>  is orally administrable and rapidly absorbed in the blood. Currently no adverse effects of<unk>  are known due to a lack of research, although thromboxane A2 synthase devisentie could be a potential risk.
Furegrelate
Lemborexant
Fosaprepitant
Tezacaftor
Eteplirsen
Protokylol
Prasugrel
Bocasan